Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Ma (Barcelona, Spain), M. Cruz (Barcelona, Spain), C. Romero-Mesones (Barcelona, Spain), I. Ojanguren (Barcelona, Spain), D. Clofent (Barcelona, Spain), D. Varona (Barcelona, Spain), X. Muñoz (Barcelona, Spain). Study of the inflammatory phenotype of asthmatic patients with bronchiectasis. 4094

Member's Comments

No comment yet.

Related content which might interest you: Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 Role of colonization on inflammation in COPD patients with bronchiectasis Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Role of neutrophils in airway inflammation in patients with pneumoconiosis and COPD Source: Eur Respir J 2004; 24: Suppl. 48, 322s Year: 2004 Inflammatory cell counts in induced sputum from non-allergic asthmatics and COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 317s Year: 2004 Smoking and airway inflammation in asymptomatic subjects and in patients with chronic airway disease Source: Eur Respir J 2002; 20: Suppl. 38, 90s Year: 2002 Small airways disease and peripheral eosinophilia predict airway hyperresponsiveness in Irish patients with suspected asthma Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Neutrophilic inflammation in severe asthmatics and COPD patients with the same severity of airway obstruction Source: Eur Respir J 2002; 20: Suppl. 38, 505s Year: 2002 Characteristics and mechanisms of bronchial hyper-responsiveness in symptomatic subjects with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 209s Year: 2003 Association between eosinophilic airway inflammation and T-cells response in children with bronchial asthma Source: Annual Congress 2010 - Mechanisms and modulation of allergic inflammation in the lung Year: 2010 Systemic and airway inflammation and the presence of emphysema in patients with COPD Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 Evolution of cellular inflammatory pattern in induced sputum in patients with mild-moderate asthma for five years Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 Inflammatory mediators in eosinophilic COPD phenotype and asthma with fixed airflow obstruction Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases Year: 2018 Heterogeneous response of airway eosinophilia to biologics in severe asthma patients Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021 Clinical outcome of eosinophilic airway inflammation in chronic airway diseases including nonasthmatic eosinophilic bronchitis Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017 Characteristics of eosinophilic and neutrophilic inflammation of bronchi of the bronchial asthma (BA) patients Source: Eur Respir J 2001; 18: Suppl. 33, 32s Year: 2001 Effects of omalizumab on markers of eosinophilic inflammation in patients with severe allergic asthma Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Sputum induction elicits different peripheral airways responses in healthy subjects, asthma and allergic rhinitis patients Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015 Clinical response to mepolizumab in patients with severe eosinophilic asthma Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019 Bronchial reversibility and airway inflammation in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 436s Year: 2003 Associations between inflammatory endotypes and phenotypes of obesity at young patients with bronchial asthma Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities Year: 2020